donepezil has been researched along with benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blandina, P; Costa, A; Passani, MB; Provensi, G | 1 |
1 other study(ies) available for donepezil and benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)-
| Article | Year |
|---|---|
Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse.
Topics: Animals; Benzofurans; Brain; Cholinesterase Inhibitors; Cognition; Donepezil; Drug Inverse Agonism; Histamine; Histamine H3 Antagonists; Histidine Decarboxylase; Indans; Male; Mice; Mice, Knockout; Nootropic Agents; Piperidines; Pyrrolidines; Receptors, Histamine H3 | 2016 |